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© 2010 The Japan Society of Histochemistry and Cy- Recent studies have suggested implications for α-synuclein cytotoxicity in the patho-
mechanism of multiple system atrophy (MSA). Given in vitro evidence that α-synuclein
generates oxidative stress, it is proposed that lipid peroxidation may be accelerated in
MSA. To address this issue, we performed an immunohistochemical analysis of protein-
bound 4-hydroxy-2-nonenal (P-HNE) in sections of archival, formalin-fixed, paraffin-embedded
pontine materials of eight sporadic MSA patients and eight age-matched control subjects.
In the MSA cases, P-HNE immunoreactivity was localized in all of the neuronal cytoplasmic
inclusions and glial cytoplasmic inclusions, both of them identified with α-synuclein and
ubiquitin. It was also detectable in reactive astrocytes and phagocytic microglia but undetect-
able in activated microglia. By contrast, P-HNE immunoreactivity in the control cases was
only very weak or not at all in the parenchyma including neurons and glia. The present
results provide in vivo evidence that HNE participates in α-synuclein-induced cytotoxicity
and neuroinflammation in MSA.
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I. Introduction
Multiple system atrophy (MSA) is a neurodegenera-
tive disease characterized by selective involvement of the
pontocerebellar, striatonigral, and autonomic systems, cor-
responding to the classical clinical entities such as olivo-
pontocerebellar atrophy (OPCA), striatonigral degeneration
(SND) and Shy-Drager syndrome (SDS), respectively [41].
Compelling evidence identifies α-synuclein cytotoxicity
in the pathological processes of α-synucleinopathies includ-
ing neurodegenerative disorders such as MSA as well as
Parkinson’s disease [9, 10, 39, 42]. Several studies focused
on implications for aggregation and ubiquitination of α-
synuclein molecules [21, 26] in neuronal cytoplasmic inclu-
sions (NCIs) and (oligodendro)glial cytoplasmic inclusions
(GCIs), both of which are known to be pathognomonic hall-
marks of MSA and appear in the affected systems [40, 41].
Recent investigations have documented the occurrence
of oxidative stress in human MSA and its animal models
[8, 18, 33] as well as in vitro evidence that α-synuclein
molecules generate oxidative stress [34]. It is well known
that oxidative stress gives rise to the formation of oxidative
modification products derived from nucleic acids, proteins
and lipids [11]. A previous study demonstrated oxidative
injury evidenced by the presence of 4-hydroxy-2-nonenal
(HNE) in Purkinje cells in the cerebellum of patients with
OPCA [43]. HNE, a member of 4-hydroxyalkenals, is a well
characterized lipid peroxidation product derived from n-6
polyunsaturated fatty acids (PUFAs), including linoleic and
γ-linoleinic acids; it attacks and modifies protein amino
acid residues to form its protein-bound forms such as
“hemiacetal adduct” with histidine, cysteine or lysine,
“pyrrole adduct” with lysine, and “fluorescent crosslinker”
with lysine (Fig. 1) [38]. These processes give rise to stress
response such as expression of proinflammatory gene pro-Shibata et al. 70
ducts including monocyte chemoattractant protein-1 (MCP-
1) and cyclooxygenase-2 (COX-2) in macrophages [20, 25].
Given such conditions, it is plausible that HNE triggers
neuroinflammation in MSA. However, the relationship
between  α-synuclein aggregation, lipid peroxidation, and
glial inflammatory response in MSA has not been fully
understood. To address this issue, we investigated and
compared immunohistochemical localizations of protein-
bound HNE (P-HNE), α-synuclein, ubiquitin and glial cell
markers in MSA pons, which is essentially involved in this
disease.
II. Materials and Methods
Subjects
This study was performed after obtaining written con-
sent from the family member of each case, in accordance
with the Declaration of Helsinki, and carried out on archival,
formalin (10%)-fixed, paraffin-embedded brain stem pon-
tine materials of eight sporadic MSA patients (age: 55–68
yr; sex: 4 males and 4 females) and eight age-matched
control subjects (age: 52–68; sex: 6 males and 2 females).
There was no significant difference in age at death between
the control and MSA groups (P>0.8 by unpaired Student’s
t-test). The clinical features of the cases examined are
summarized in Table 1. Multiple 6-μm-thick sections of
each pons were used for histopathological staining with
hematoxylin-eosin (H&E) and Klüver-Barrera (K&B) and
for immunohistochemical staining.
Antibodies
The primary antibodies employed in immunohisto-
chemistry were mouse monoclonal IgG1 against P-HNE
(Clone HNEJ2; NOF, Tokyo, Japan) at a concentration
of 0.1 μg/mL, rabbit polyclonal IgG against α-synuclein
(Cat. No. 18671; IBL, Fujioka, Japan) at a concentration of
1 μg/mL, rabbit polyclonal IgG against ubiquitin (Cat. No.
Z458; Dako, Glostrup, Denmark) at a dilution of 1:1,000,
rabbit polyclonal IgG against glial fibrillary acidic protein
(GFAP) (Cat. No. GTX16997; GeneTex; Irvine, CA, USA)
at a dilution of 1:1,000, and rabbit polyclonal IgG against
glucose transporter-5 (GLUT5) (Cat. No. 18905; IBL) at a
concentration of 0.5 μg/mL. Of these antigens, GFAP and
GLUT5 were used as histological markers of astrocytes and
microglia, respectively. As described in the data sheet, the
antibody HNEJ2 specifically recognizes hemiacetal adduct
with histidine among the protein-bound forms of HNE [37].
Immunohistochemical staining
Sections were deparaffinized, rehydrated, quenched for
10 min at room temperature with 3% hydrogen peroxide,
rinsed in phosphate-buffered saline, pH 7.6 (PBS), pre-
treated for 20 min at room temperature with 3% bovine
Fig. 1. Schematic diagram showing nonenzymatic processes of n-6
polyunsaturated fatty acid (PUFA) peroxidation and subsequent
protein carbonylation to form several protein adducts of 4-hydroxy-
2-nonenal (HNE). His, Cys, and Lys indicate protein amino acid
residues of histidine, cysteine, and lysine, respectively.
Table 1. Clinical features of examined cases
Abbreviations: F, female; M, male; MSA, multiple system atrophy;
OPCA, olivopontocerebellar atrophy; SDS, Shy-Drager syndrome;
SND, striatonigral degeneration.
Case 
No.
Age at 
death Sex Disease (phenotype)
1 55 M MSA (SDS)
2 55 F MSA (SDS)
3 57 F MSA (SND)
4 59 F MSA (OPCA)
5 61 M MSA (OPCA)
6 62 M MSA (SDS)
7 65 M MSA (SDS)
8 68 F MSA (SND)
94 6F S e p s i s
10 53 F Middle ear carcinoma
11 55 F Systemic lupus erythematosus
12 66 M Panhypopituitarism
13 68 F Cardiac valvular disease
14 73 M Pancreatic carcinoma
15 75 M Sepsis
16 87 M Cardiac valvular diseaseHNE in Multiple System Atrophy 71
serum albumin (BSA) in PBS, and then incubated over-
night at 4°C with the primary antibodies. Antibody bind-
ing was visualized by the polymer-immunocomplex (PIC)
method using the appropriate EnVision system (Dako).
3,3'-Diaminobenzidine tetrahydrochloride (DAB) was the
chromogen, and hematoxylin, the counterstain. Sections
processed with omission of the primary antibodies or incu-
bated with nonimmune serum derived from the same animal
species as those producing the antibodies gave negative
reaction controls. The specificity of the anti-P-HNE anti-
body on sections was comfirmed by preimmunoabsorption
test; sections were incubated with the antibody preincubated
with 1 mg/mL BSA-HNE conjugates in PBS.
Immunohistochemical evaluation
Immunohistochemical localization of P-HNE was
verified by comparison with consecutive sections stained
with H&E and immunostained with the antibodies to α-
synuclein, ubiquitin, GFAP, and GLUT5, and it was also
identified by the double-immunolabeled staining method as
described previously [32]. Sections were incubated with one
antibody, and immunoreaction was detected by the PIC
method using DAB as the chromogen. After taking micro-
photographs, sections were processed by eluting the immune
complex by microwaving (400 W, 95°C, 10 min) in citrate
buffer, pH 6.0, and these sections were subsequently incu-
bated with another antibody. Immunoreaction was detected
by the PIC method using NiCl2/DAB as the chromogen.
Immunohistochemical localizations of the examined sub-
stances on NiCl2/DAB-colored sections were compared
with the initially taken microphotographs at the correspond-
ing regions of DAB-colored sections.
III. Results
Histopathological observations
Histopathological examination revealed that the MSA
pons showed the characteristic features of this disease as
described previously [41], whereas the control pons dis-
played no significant abnormality. In brief, at a low mag-
nification of K&B-stained sections, the MSA patients
showed prominent atrophy of pontine base and myelin pallor
of transverse fibers (Fig. 2b), while the control subjects
seemed to be morphologically intact (Fig. 2a). At a higher
magnification of H&E-stained sections, the MSA cases
exhibited atrophy and reduced number of pontine neurons,
reactive gliosis, and appearance of NCIs and GCIs (Fig.
2d), but by contrast the control cases did not show any
histological alteration (Fig. 2c).
Immunohistochemical observations
Immunoreaction products were invisible on sections
processed for negative reaction control (Fig. 2g) and pre-
immunoabsorption test of the anti-P-HNE antibody (Fig.
2h). P-HNE immunoreactivity was only very weak or not
at all in the control cases (Fig. 2e). In the MSA cases, the
immunoreactivity was mainly distributed in the pontine
base and distinct in the abnormal structures NCIs and GCIs,
as well as the cytoplasm of all of the normal-looking and
degenerative pontine neurons and reactive glia, and it was
more intense in these abnormal structures (Fig. 2f). As
described in the literature [7], microglial morphology in
pathological conditions was defined as the following:
activated microglia were characterized by thin perikarya
and double-branching, arborized, thick cell processes, and
phagocytic microglia were characterized by hypertrophic
perikarya. Moreover, activated microglia were scattered in
the MSA lesions (Fig. 3h), while phagocytic microglia were
aggregated to constitute so-called glial nodules (Fig. 3j).
P-HNE immunoreactivity in the MSA pons was colocal-
ized with all of the NCIs and GCIs immunoreactive for
α-synuclein (Fig. 3a, b) and ubiquitin (Fig. 3c, d), and it was
also detectable in almost all of the GFAP-immunoreactive
reactive astrocytes in the lesions (Fig. 3e, f) and GLUT5-
immunoreactive “aggregated” phagocytic microglia (Fig. 3i,
j) but not in any of the GLUT5-immunoreactive “scattered”
activated microglia (Fig. 3g, h). No distinct α-synuclein
immunoreactivity was detectable in GFAP-immunoreactive
astrocytes (Fig. 4a, b) or GLUT5-immunoreactive micro-
glia (Fig. 4c, d) in the MSA cases. There was no significant
difference in these immunohistochemical results among the
MSA cases.
IV. Discussion
In the present study, noteworthy was the coexistence
of P-HNE accumulates with α-synuclein- and ubiquitin-
containing NCIs and GCIs in the MSA pons. These observa-
tions suggest a close link between α-synuclein, ubiquitin,
and HNE in the pathomechanism of MSA. A number of
investigations have indicated that oligomers of α-synuclein
molecules generate reactive oxygen species (ROS) such as
hydrogen peroxide and hydroxyl radical [35], which are
responsible for lipid peroxidation [11, 38]. The representa-
tive lipid peroxidation product HNE modifies and crosslinks
amino acid residues of α-synuclein to promote molecular
aggregation of this protein [28]. HNE also inhibits normal
proteasomal and lysosomal functions but not ubiquitination
in neurons [4, 5, 15, 17], impairs glutamate and glucose
transport in neurons [16, 27], and induces programmed
cell death of neurons and oligodendrocytic progenitors [6,
19, 22]; these mechanisms are mediated by HNE-driven
oxidative stress. Thus, our results suggest a critical role
for HNE, as an α-synuclein-induced lipid peroxidation pro-
duct, in the processes of neuronal and oligodendroglial
degeneration in MSA, including ROS-induced cell damage,
inhibition of the proteolytic mechanisms, and formation of
the NCIs and GCIs.
Another interesting finding in this study was the dis-
closure of P-HNE accumulates in pontine base astrocytes
and microglia in the MSA cases. Given that α-synuclein
immunoreactivity was localized in NCIs and GCIs, it is
likely that HNE primarily occurs in lesional neurons and
oligodendroglia in the processes of α-synuclein aggregationShibata et al. 72
Fig. 2. Semimacroscopic findings of Klüver-Barrera-stained pontine sections (a, b) and microscopic findings of pontine nucleus sections
stained with hematoxylin-eosin (c, d) and immunostained for  protein-bound 4-hydroxy-2-nonenal (e, f) in control subjects (a, c, e) and multiple
system atrophy (MSA) patients (b, d, f). Panels (g, h) indicate negative reaction control and preimmunoabsorption test sections, respectively,
in MSA pontine nuclei. Polymer-immunocomplex method using 3,3'-diaminobenzidine tetrahydrochloride (brown in e–h) as the chromogen.
Arrows and arrowheads indicate neuronal cytoplasmic inclusions and glial cytoplasmic inclusions, respectively. Bars=5 mm (a, b) and 100 μm
(c–h).HNE in Multiple System Atrophy 73
and diffuses into the surrounding parenchyma. The finding
that  α-synuclein immunoreactivity was undetectable in
astrocytes and microglia suggests that these cells digested
this protein after uptake. The lack of P-HNE immuno-
reactivity in activated microglia may result from evidence
that these cells promptly scavenge HNE via their strong
antioxidative defense system using a large amount of intra-
cellular glutathione produced by cystine that is taken up
Fig. 3. Immunohistochemical comparison of protein-bound 4-hydroxy-2-nonenal (a, c, e, g, i) with α-synuclein (b), ubiquitin (d), glial fibrillary
acidic protein (f) and glucose transporter-5 (h, j) in pontine sections from multiple system atrophy patients. Panels (b, d, f, h, j) including
their insets indicate double staining at the identical regions on the same sections as panels (a, c, e, g, i), respectively. Large blank and solid
arrows indicate atrophic pontine neurons and neuronal cytoplasmic inclusions, respectively. Blank and solid arrowheads indicate normal-
appearing pontine neurons and glial cytoplasmic inclusions, respectively. Small blank and solid arrows indicate activated microglia scattered in
the neuropil and phagocytic microglia composing a glial nodule, respectively. Polymer-immunocomplex method using 3,3'-diaminobenzidine
tetrahydrochloride (DAB) (brown in a, c, e, g, i) and nickel dichloride (NiCl2)/DAB (blue in b, d, f, h, j) as the chromogen. Bar=100 μm (a–j).Shibata et al. 74
from the extracellular space in return for HNE-induced
glutamate release [1]. The fact that P-HNE accumulates
were detectable in reactive astrocytes and phagocytic micro-
glia points to the possibility that these glial cells may phago-
cytose extracellular P-HNE or undergo intracellular protein
adduct formation of HNE diffused from the extracellular
space. This discrepancy of P-HNE immunostaining between
phagocytic and activated forms of microglia may reflect a
difference in property of these cells [7].
Glial activation has been observed in the brain lesions
of MSA patients and α-synuclein-overexpressing mice as an
animal model of this disease [13, 34]. A number of studies
have demonstrated that HNE impairs glutamate uptake by
astrocytes and microglia and promotes glutamate release
from these glial cells [1–3, 36], leading to exposure of
neurons and oligodendrocytes to an excess of extracellular
glutamate. It has been shown that an imbalance of glial
glutamate release and uptake interacts with neuroinflam-
mation [36]. Activated microglia modulate expression of
astroglial enzymes responsible for oxidative and inflamma-
tory stimuli [30]. Furthermore, several studies have focused
on the role of α-synuclein in lipid peroxidation metabolism
and downstream inflammatory response in the brain [10].
In fact, upregulation of proinflammatory gene products has
been shown in reactive astrocytes and activated microglia
in neurodegenerative diseases such as Alzheimer’s disease,
Parkinson’s disease, and amyotrophic lateral sclerosis [12,
23, 29], all of which are associated with increased tissue
HNE levels [14, 24, 31]. These observations could indicate
that glial cells in MSA lesions participate in local inflamma-
tion in response to oxidative stress.
Taken together, we demonstrated the accumulation of
P-HNE in NCIs, GCIs, reactive astrocytes, and phagocytic
microglia, but not activated microglia in MSA pontine
lesions. Our results suggest the involvement of HNE-
mediated cytotoxic effects on pontine neurons and oligo-
dendroglia in association with the formation of NCIs and
GCIs, as well as inflammatory response and glutamate
toxicity by astrocytes and microglia. Elucidating the mech-
anism by which α-synuclein-induced HNE production is
regulated in the central nervous system will contribute to
a better understanding of MSA and establishment of thera-
peutic strategies for this disease.
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